Скачать или смотреть Revolutionary Antibody Could Replace IVIG Therapy for Autoimmune Diseases

Rockefeller University scientists have engineered a next-generation antibody that could replace IVIG therapy for autoimmune conditions. This breakthrough offers a more effective and accessible treatment option.
IVIG therapy, while widely used, suffers from limitations like high cost, supply shortages, and lengthy infusions. This new engineered antibody delivers the same effectiveness at a fraction of the dose in mice and can be synthesized without human plasma.
Learn about the science behind this innovative approach, which builds upon 40 years of research on Fc receptors and a deeper understanding of anti-inflammatory pathways. This could revolutionize the treatment of autoimmune diseases like arthritis and multiple sclerosis.